Drugs / cA2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00004941 | Jul 1996 | Crohn disease | FDA Office of Orphan Products Development | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cA2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004941 ↗ |
| Modality | Monoclonal antibody | “chimeric monoclonal antibody (cA2)” NCT00004941 ↗ |